Consultant- Biotechnology
Vancouver, Canada Area
Consultant- Biotechnology
Vancouver, Canada Area
Physician scientist, specialized in ophthalmology and vascular diseases of the eye with special interest in retinal vascular diseases and glaucoma.
The last 10 years dedicated to eye biomechanics with special emphasis in the application of finite element analysis, computational mathematics and artificial intelligence to develop a virtual biomechanical and optical model of the eye with applications to surgery and soft testing of new compounds/ delivery systems in glaucoma.
Evaluated the link between light exposure and breakdown of the blood-ocular barrier, with the aim to modulate inflammatory cascades via filtering specific spectra.
Since 2007 work as consultant for QLT Inc. as Director Clinical Research in the areas of retina and glaucoma.
Ophthalmology- Retina, glaucoma. Start-up in medical devices. Consulting in medical research, with interest in clinical trials phases 2-4. Pharmacovigilance. Multidisciplinary teams: computational mathematics, engineering, biomaterials, biosensors, MEMS, laser interferometry, artificial intelligence, evolutionary modelling.
(Biotechnology industry)
October 2008 — Present (1 year 3 months)
Medical device company for the development of eye tonometers.
(Public Company; QLTI; Biotechnology industry)
2007 — Present (2 years )
Biotechnology company located in Vancouver, BC, Canada.
www.qltinc.com
(Privately Held; 1-10 employees; Biotechnology industry)
September 2006 — June 2007 (10 months)
Research company to develop diagnostic equipment for ophthalmology. Innovative non-contact eye tonometer to measure the intraocular pressure and screen/ monitor glaucoma.
Fellowship in Ocular vascular diseases 1986 — 1990
Special emphasis on Angterior ischemic optic neuropathy. ocular occlusive diseases, glaucoma including the development of experimental glaucoma in macacus Rhesus with systemic hypertension and hypercholesterolemia.
Visiting Scientist- Early Treatment Diabetic Retinopathy Study 1984 — 1986
Mainly working in two multicenter studies: ETDRS and the use of yellow filters and antioxidants in early AMD.
Fellowship-viteoretinal diseases 1978 — 1980
D.Sc. , Eye Pathology , 1971 — 1974
Pathology of Retinoblastoma- Cum Laude- Baudilio Curtis Prize for Prevention of blindness 1975. First prize to the best paper in experimental retinal detachment, Pan American Ophthalmology Association, 1979.
MD , 1965 — 1971
Superb faculty in basic sciences like Dr de Robertis in Histology and Dr Sampaolesi in glaucoma.
Great times and great people. The University holds two Nobel Laureates, and in spite of Argentina's political turmoils in the 60's and 70's it has been the incubator of great physicians and scientists. I am very honoured to be an alumnus of UBA.
Ophthalmology, neuroscience, computational mathematics, applied physics, bioengineering, artificial intelligence, evolution, philosophy, psychology, politics, hicking, tennis.
American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology.
First Prize "Baudilio Curtis" for the experimental work "Intravitreal dexamethasone for PVR" in 1981.
Best Early Start Biotech Company, Edmonton Investor Forum, 2001. Best Biotech Startup, Calgary 2001.